Building the CMO Playbook: From Pre-IND to Launch in Early-Stage Biotech

In this episode, Peg Crowley-Nowick speaks with Joseph Elassal, MD, MBA, Chief Medical Officer of Ankyra Therapeutics, about the strategic, operational, and financial realities of leading clinical development from pre-IND through proof of concept and toward commercialization. Drawing on experience across large pharma, biotech partnerships, and early-phase oncology, Joe shares a practical roadmap…